Skip to main content
. 2021 Mar 18;10(2):815–825. doi: 10.1007/s40121-021-00431-9

Table 2.

Estimated results on the efficacy of remdesivir treatment in reducing the high-risk COVID-19 state

Estimate
(95% CI)
14-day observation
 Low-risk

0.652

(0.580, 0.733)

 Medium-risk

0.878

(0.677, 1.140)

28-day observation
 Low-risk

0.707

(0.702, 0.712)

 Medium-risk

0.938

(0.818, 1.076)